TRACON Pharmaceuticals

+$0.20 (+3.07%) Today
-$0.09 (-1.34%) As of 12:00 AM UTC after-hours

Why Robinhood?

You can buy or sell TCON and other stocks, options, and ETFs commission-free!

About TCON

TRACON Pharmaceuticals, Inc. engages in the development and commercialization of targeted therapies for cancer, ophthalmic, and fibrotic diseases. Its products include TRC105, an anti-endoglin antibody for the treatment of solid tumor types; TRC205 created for the treatment of fibrotic diseases; and TRC102, a small molecule that is in clinical development made for lung cancer and glioblastoma.

CEO
Charles P. Theuer
Employees
18
Headquarters
San Diego, California
Founded
2004

TCON Key Statistics

Market Cap
107.51M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
135.60K
High Today
$6.76
Low Today
$6.25
Open Price
$6.46
Volume
118.52K
52 Week High
$12.20
52 Week Low
$1.55

TCON Earnings

-$1.66
-$1.11
-$0.55
$0.00
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Estimated
— per share
Actual
Expected Aug 4, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure